Cranleigh, United Kingdom

Kong Luk


Average Co-Inventor Count = 2.4

ph-index = 3

Forward Citations = 35(Granted Patents)


Location History:

  • Cranleigh, GB (1978 - 1982)
  • Horley, GB (1983 - 1984)

Company Filing History:


Years Active: 1978-1984

Loading Chart...
19 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Kong Luk in Antibacterial Compounds

Introduction

Kong Luk, based in Cranleigh, GB, stands out as an influential inventor with a remarkable portfolio of 19 patents. His work primarily focuses on the development of antibacterial compounds and innovative processes in the pharmaceutical realm.

Latest Patents

Among Kong Luk's latest inventions are significant advancements in antibacterial compounds, specifically esters of a compound referred to as 'monic acid', which demonstrate activity against both Gram-positive and Gram-negative organisms. Another noteworthy patent involves a process for preparing a fused bicyclic β-lactam containing compound, highlighting an optional free carboxylic acid group. This innovative process details the reaction of specific esters with halide ions, forming key components for antibiotic development.

Career Highlights

Kong Luk's career has been marked by key positions in reputable organizations, including the Beecham Group Plc and Beecham Group Limited of Beecham House. His expertise in the pharmaceutical industry has made substantial contributions to antibiotic research and development.

Collaborations

Throughout his career, Kong Luk has collaborated with esteemed colleagues, notably Norman H. Rogers and John P. Clayton. These partnerships have fostered an environment of innovation and advancement in their respective fields, leading to significant breakthroughs.

Conclusion

Kong Luk's contributions to the field of pharmaceutical sciences are remarkable and illustrate the impact of innovation in addressing critical health challenges. With an impressive number of patents and influential collaborations, he continues to shape the landscape of antibacterial research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…